RYNEX PSE
NDC 0485-0206, BROMPHENIRAMINE MALEATE and PSEUDOEPHEDRINE HYDROCHLORIDE, liquid, from EDWARDS PHARMACEUTICALS, INC..
- Product NDC
- 0485-0206
- Status
- Listed
- Labeler
- EDWARDS PHARMACEUTICALS, INC.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0485-0206 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BROMPHENIRAMINE MALEATE1 mg/5mL
- PSEUDOEPHEDRINE HYDROCHLORIDE15 mg/5mL
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0485-0206-16 | 00485020616 | 473 mL in 1 BOTTLE, PLASTIC (0485-0206-16) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0485-0206 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0485-0206 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0485-0206. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.